354 related articles for article (PubMed ID: 19155081)
1. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
Sharma P; Kumar A; Sharma BC; Sarin SK
J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis.
Spahr L; Giostra E; Frossard JL; Bresson-Hadni S; Rubbia-Brandt L; Hadengue A
J Hepatol; 2004 Aug; 41(2):229-34. PubMed ID: 15288471
[TBL] [Abstract][Full Text] [Related]
3. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.
Altamirano J; Higuera-de laTijera F; Duarte-Rojo A; Martínez-Vázquez MA; Abraldes JG; Herrera-Jiménez LE; Michelena J; Zapata L; Perez-Hernández J; Torre A; Gonzáles-González JA; Cardenas A; Dominguez M; Arroyo V; Ginès P; Caballería J; Bataller R
Am J Gastroenterol; 2011 Aug; 106(8):1472-80. PubMed ID: 21556041
[TBL] [Abstract][Full Text] [Related]
4. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
[TBL] [Abstract][Full Text] [Related]
5. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
6. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
Louvet A; Wartel F; Castel H; Dharancy S; Hollebecque A; Canva-Delcambre V; Deltenre P; Mathurin P
Gastroenterology; 2009 Aug; 137(2):541-8. PubMed ID: 19445945
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis.
Altamirano J; Fagundes C; Dominguez M; García E; Michelena J; Cárdenas A; Guevara M; Pereira G; Torres-Vigil K; Arroyo V; Caballería J; Ginès P; Bataller R
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):65-71.e3. PubMed ID: 21946124
[TBL] [Abstract][Full Text] [Related]
8. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.
Daswani R; Kumar A; Anikhindi SA; Sharma P; Singla V; Bansal N; Arora A
Indian J Gastroenterol; 2018 Mar; 37(2):141-152. PubMed ID: 29704174
[TBL] [Abstract][Full Text] [Related]
9. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.
Naveau S; Chollet-Martin S; Dharancy S; Mathurin P; Jouet P; Piquet MA; Davion T; Oberti F; Broët P; Emilie D;
Hepatology; 2004 May; 39(5):1390-7. PubMed ID: 15122768
[TBL] [Abstract][Full Text] [Related]
10. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study.
Spahr L; Rubbia-Brandt L; Frossard JL; Giostra E; Rougemont AL; Pugin J; Fischer M; Egger H; Hadengue A
J Hepatol; 2002 Oct; 37(4):448-55. PubMed ID: 12217597
[TBL] [Abstract][Full Text] [Related]
11. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
Louvet A; Labreuche J; Artru F; Boursier J; Kim DJ; O'Grady J; Trépo E; Nahon P; Ganne-Carrié N; Naveau S; Diaz E; Gustot T; Lassailly G; Cannesson-Leroy A; Canva-Delcambre V; Dharancy S; Park SH; Moreno C; Morgan TR; Duhamel A; Mathurin P
Gastroenterology; 2015 Aug; 149(2):398-406.e8; quiz e16-7. PubMed ID: 25935634
[TBL] [Abstract][Full Text] [Related]
12. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial.
Korhonen T; Karppinen J; Paimela L; Malmivaara A; Lindgren KA; Bowman C; Hammond A; Kirkham B; Järvinen S; Niinimäki J; Veeger N; Haapea M; Torkki M; Tervonen O; Seitsalo S; Hurri H
Spine (Phila Pa 1976); 2006 Nov; 31(24):2759-66. PubMed ID: 17108825
[TBL] [Abstract][Full Text] [Related]
13. Invasive aspergillosis in patients with severe alcoholic hepatitis.
Gustot T; Maillart E; Bocci M; Surin R; Trépo E; Degré D; Lucidi V; Taccone FS; Delforge ML; Vincent JL; Donckier V; Jacobs F; Moreno C
J Hepatol; 2014 Feb; 60(2):267-74. PubMed ID: 24055548
[TBL] [Abstract][Full Text] [Related]
14. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.
Srikureja W; Kyulo NL; Runyon BA; Hu KQ
J Hepatol; 2005 May; 42(5):700-6. PubMed ID: 15826720
[TBL] [Abstract][Full Text] [Related]
15. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
Stewart S; Prince M; Bassendine M; Hudson M; James O; Jones D; Record C; Day CP
J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.
Rudler M; Mouri S; Charlotte F; Lebray P; Capocci R; Benosman H; Poynard T; Thabut D
J Hepatol; 2015 Apr; 62(4):816-21. PubMed ID: 25450199
[TBL] [Abstract][Full Text] [Related]
19. MELD accurately predicts mortality in patients with alcoholic hepatitis.
Dunn W; Jamil LH; Brown LS; Wiesner RH; Kim WR; Menon KV; Malinchoc M; Kamath PS; Shah V
Hepatology; 2005 Feb; 41(2):353-8. PubMed ID: 15660383
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.
Singh V; Sharma AK; Narasimhan RL; Bhalla A; Sharma N; Sharma R
Am J Gastroenterol; 2014 Sep; 109(9):1417-23. PubMed ID: 24935272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
